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Early & Periodic Screening, Diagnosis & Treatment
Screening for Depression in Primary Practice
by Tammy Wilgenbusch, PhD
Department of Pediatrics • University of Iowa Children’s Hospital
Depression is a mental health 
disorder that affects millions 
of children and adolescents 
each year.  Symptoms include 
persistent and debilitating sad-
ness, loss of interest in activi-
ties, discouragement, physical 
symptoms, changes in sleep-
ing and eating habits, and loss 
of self-worth. Reports from the 
Substance Abuse and Mental 
Health Services Administra-
tion (SAMHSA) estimate that 
approximately 8.5% of those 
ages 12 to 17 experienced one 
major depressive episode in 
the past year, with females be-
ing twice as likely to have had 
a depressive episode. Of these 
youths, approximately 70% 
indicated that they suffered se-
vere or very severe impairment 
in at least one of the following 
areas: home, school/work, fam-
ily relationships, or social life. 
This impairment left them un-
able to carry out their normal 
daily activities for between 25 
to 58 days that year. 
These statistics make clear that 
depression can be debilitating 
for children and adolescents, 
yet only 38.9% of these youths 
reported that they received 
some sort of treatment for 
their depression. Among those 
who received treatment, 36.8% 
saw a psychologist, 27.3% 
saw a psychiatrist, and 26.6% 
saw their general practitioner. 
There are many reasons youth 
may not receive treatment, 
including not recognizing or 
understanding their symptoms 
and the stigma surrounding 
mental health. The low number 
who seek treatment compared 
to the number who report 
severe impairment makes 
clear that more needs to be 
done to identify children and 
adolescents with depression. 
 EPSDT Care for Kids Newsletter    Winter 2013    http://www.iowaepsdt.org/EPSDTNews/  
• 2 •
Screening for Depression in Primary Practice   
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Pediatricians and other practi-
tioners who follow youth on an 
on-going basis are in a prime 
position to identify depression 
symptoms. Early identification 
and appropriate treatment 
may lessen the likelihood of 
severe impairment.
There are several measures 
that may help practitioners 
screen for depression in chil-
dren and adolescents during 
routine primary care visits. 
The Children’s Depression 
Inventory 2 (CDI 2) is a well-
normed self-reporting mea-
sure for those from 7 to 17 
years of age. Having parents 
and teachers complete ap-
propriate versions of the 
inventory provides additional 
information. The original ver-
sion contains 28 items and 
looks at several aspects of 
depression including negative 
mood, negative self-esteem, 
interpersonal problems, and 
ineffectiveness. For a primary 
care setting, there is a 10-item, 
short version of the CDI 2 that 
could easily be integrated into 
routine visits. 
For adolescents and adults, the 
Beck Depression Inventory-
FastScreen (BDI-FS) is a self-
reporting measure that has 
shown to have good sensitivity 
and specificity. The seven-item 
FastScreen is normed for ages 
13 to 80, so it is appropriate for 
wide patient population. The 
BDI-FS is a new, shorter ver-
sion of the BDI-II,which is well 
suited for the quick pace of 
busy primary care clinics. 
Another screening tool for 
depression is the Center for 
Epidemiologic Studies Depres-
sion Scale for Children (CES-
DC). While this 20-item mea-
sure has been used for children 
as young as 8 years old, psy-
chometric properties indicate 
that it is more appropriate for 
ages 11 to 18. An adult version 
also is available: both instru-
ments have been widely used 
for clinical and epidemiological 
research. A version of the CES-
DC can be found in the Bright 
Futures Clinical Toolbox.
In addition to depression, the 
Pediatric Symptoms Checklist 
(PSC) and Strengths and Dif-
ficulties Questionnaire (SDQ) 
screen for a variety of internaliz-
ing and externalizing behaviors 
in children and adolescents.
The Pediatric Symptom Check-
list (PSC) is a tool that uses a 
Likert scale to assess a wide 
range of mental health and be-
havioral symptoms. It is avail-
able in an original 35-item ver-
sion or a 17-item short version 
(PSC-17) and is appropriate for 
ages 4 to18. There are forms for 
parents to complete, as well as 
a self-report for older children 
and adolescents. Both forms 
suggest specific cutoff scores 
that indicate further evaluation 
may be warranted.
The Strengths and Difficul-
ties Questionnaire (SDQ) is 
a screening tool that often 
is used both clinically and in 
research. The main screening 
tool contains 25 items ask-
ing about symptoms in five 
different areas: emotional 
symptoms, conduct prob-
lems, hyperactivity/inatten-
tion, peer relationships, and 
prosocial behavior. The SDQ 
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is appropriate for those ages 
3 to 16 and there are several 
versions available for comple-
tion by parents, teachers, and 
a self-report for youths 11 to 
16 years old. Extended ver-
sions include the impact of the 
symptoms on the youth and 
follow-up questions following 
an intervention.
Completion of any screen-
ing tool will provide valuable 
information about depression 
symptoms and a good start-
ing point for interviewing 
and talking with children and 
adolescents about depres-
sion and other mental health 
issues. While not every child 
who scores high on a screen-
ing tool will have significant 
difficulties, these tools will 
help you as a primary care 
practitioner to identify those 
of depression in childhood and
adolescence: An evaluation of 
the Center for Epidemiological 
Studies Depression Scale for
Children (CES-DC). Ameri-
can Journal of Psychiatry 
143(8):1024–1027.
Screening for Depression in Primary Practice   
(continued from page 2)
Screening Tool Cost Source
CDI 2
$84.00 for manual
$53 for pkg of 25 Record Forms
http://psychcorp.org
BDI-FastScreen
$99.00 for complete kit






SDQ No Fee http://www.sdqinfo.com
PSC and PSC-17 No Fee http://psc.partners.org
patients who should be re-
ferred for further evaluation or 
treatment by a mental health 
professional.
Resources
Substance Abuse and Mental 
Health Services Administration, 
Office of Applied Studies. (May 
11, 2009). The NSDUH Report: 
Major Depressive Episode and 
Treatment among Adolescents. 
Rockville, MD.
Substance Abuse and Mental 
Health Services Administra-
tion, Office of Applied Studies. 
(May 13, 2008). The NSDUH Re-
port—Major Depressive Episode 
among Youths Aged 12 to 17 in 
the United States: 2004 to 2006. 
Rockville, MD.
Faulstich ME, Carey MP, Rug-
giero L, et al. 1986. Assessment 
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Coronary Artery Risk Detection 
in Appalachian Communities 
project was conducted. This 
study evaluated more than 
20,000 fifth-grade children in 
West Virginia. Of the 29% who 
did not have a positive family 
history, 9.5% had a dyslipid-
emia. Of these children, more 
than 100 warranted pharmaco-
logic therapy. The obesity epi-
demic also has led to a much 
larger population of children 
with dyslipidemia, changing 
the clinical picture drastically. 
In addition, the knowledge 
base regarding dyslipidemias 
in childhood has changed. It 
is becoming clearer that cu-
mulative exposure to elevated 
cholesterol levels appears to 
be associated with cardiovas-
cular risk later in life. In order 
to address these concerns, 
newer guidelines needed to be 
established. 
In 2011, screening guide-
lines were published which 
included a universal screen-
ing component. Criticism of 
universal screening included 
the unintentional labeling of 
children with a “disease,” lead-
ing to anxiety for them and 
their families, as well as esti-
mates of increased cholesterol-
lowering medication use when 
long-term safety and efficacy 
studies have not performed. 
Although these controversies 
Pediatric Lipid Screening Guidelines 
by Sonali Patel, MD, PhD,  Pediatric Cardiology, University of Iowa Children’s Hospital
Cardiovascular disease is the 
leading cause of mortality and 
morbidity in the United States. 
While most occurs during 
adulthood, the percentage of 
individuals with cardiac dis-
ease is exponentially increas-
ing. Projections estimate that 
over 40% of adults will have 
cardiovascular disease by the 
year 2030. It is important to 
note that this is an acquired 
disease. Autopsy studies and 
studies of accident, trauma, 
and homicide victims make 
clear that the atherosclerotic 
process begins in childhood. 
The progression from fatty 
streaks to fibrous plaque to 
atherosclerotic plaque has 
been well characterized. It also 
has been estimated that 50% 
of the pediatric population has 
evidence of fatty streaks, with 
much smaller percentages 
comprising the remaining two 
stages. Using the adult popu-
lation as a reference, it has 
been demonstrated that risk 
reduction delays progression 
to clinical disease. Armed with 
this knowledge, it is becoming 
increasingly important that 
cardiovascular risk reduction 
take place during childhood.
The prevalence of lipid abnor-
malities in childhood is increas-
ing. The Child and Adolescent 
for Cardiovascular Health Trial 
evaluated over 3,000 third-
grade students and discovered 
that more than 13% of seem-
ingly healthy children had total 
cholesterol levels over 200 mg/
dL. Using the National Health 
and Nutrition Examination Sur-
vey data from 1988-1994, 10% 
of adolescents were identified 
as having an elevated total 
cholesterol. More recent data 
from 1999-2006 has identi-
fied over 20% of adolescents 
with not only an elevated total 
cholesterol, but also more than 
one lipid abnormality. 
In 1992, screening guidelines 
were published by the Ameri-
can Academy of Pediatrics 
based on a targeted screening 
approach. High-risk individuals 
were identified based on fam-
ily history of hypercholesterol-
emia, hypertension, diabetes, 
or early cardiovascular events. 
Individuals also were classi-
fied as high-risk if there were 
cardiovascular risk factors 
present such as overweight or 
obese weight status, hyperten-
sion, or diabetes. In an effort to 
evaluate these guidelines, the 
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Center for Epidemiological Studies
Depression Scale for Children (CES-DC)
The Center for Epidemiological Stud-
ies Depression Scale for Children 
(CES-DC) is a 20-item self-report 
depression inventory with possible 
scores ranging from 0 to 60. Each 
response to an item is scored as fol-
lows: 0 = “Not At All”
 1 = “A Little”
 2 = “Some”
 3 = “A Lot”
However, items 4, 8, 12, and 16 are 
phrased positively, and thus are 
scored in the opposite order:
 3 = “Not At All”
 2 = “A Little”
 1 = “Some”
 0 = “A Lot”
Higher CES-DC scores indicate in-
creasing levels of depression. Weiss-
man et al. (1980), the developers of 
the CES-DC, have used the cutoff 
score of 15 as being suggestive of 
depressive symptoms in children and 
adolescents. That is, scores over 15 
can be indicative of significant levels 
of depressive symptoms. 
Remember that screening for depres-
sion can be complex and is only an 
initial step. Further evaluation is 
required for children and adoles-
cents identified through a screening 
process. Further evaluation is also 
warranted for children or adolescents 
who exhibit depressive symptoms 
but who do not screen positive.
This inventory is from Bright Futures, 
where more resources for families can 
be found (www.brightfutures.org).
REFERENCES
Weissman MM, Orvaschel H, Padian N. 
1980. Children’s symptom and social 
functioning selfreport scales: Comparison 
of mothers’ and children’s reports. Journal 
of Nervous Mental Disorders 168(12):736–
740.
Faulstich ME, Carey MP, Ruggiero L, et 
al. 1986. Assessment of depression in 
childhood and adolescence: An evalu-
ation of the Center for Epidemiological 
Studies Depression Scale for Children 
(CES-DC). American Journal of Psychiatry 
143(8):1024–1027. 
Number ____________________ Score ______________________
INSTRUCTIONS
Below is a list of the ways you might have felt or acted. Please check how much you have felt this way during the past week.
 DURING THE PAST WEEK  Not At All  A Little  Some  A Lot
  1. I was bothered by things that usually don’t bother me.  . . . . . . . .o . . . . . . . . . . . . . o . . . . . . . . . . . . . . o . . . . . . . . . . . . . o 
  2. I did not feel like eating, I wasn’t very hungry. . . . . . . . . . . . . . . . . . .o  . . . . . . . . . . . . . o . . . . . . . . . . . . . . o . . . . . . . . . . . . . o 
  3. I wasn’t able to feel happy, even when my family or 
 friends tried to help me feel better. . . . . . . . . . . . . . . . . . . . . . . . . . . . .  o . . . . . . . . . . . . . o . . . . . . . . . . . . . . o . . . . . . . . . . . . .o  
  4.  I felt like I was just as good as other kids.  . . . . . . . . . . . . . . . . . . . . . .o  . . . . . . . . . . . . . o . . . . . . . . . . . . . . o . . . . . . . . . . . . . o 
  5.  I felt like I couldn’t pay attention to what I was doing.  . . . . . . . . . .o . . . . . . . . . . . . . o . . . . . . . . . . . . . . o . . . . . . . . . . . . .o 
 DURING THE PAST WEEK  Not At All  A Little  Some  A Lot
  6.  I felt down and unhappy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .o  . . . . . . . . . . . . . o . . . . . . . . . . . . . . o . . . . . . . . . . . . .o 
  7.  I felt like I was too tired to do things.  . . . . . . . . . . . . . . . . . . . . . . . . . .o  . . . . . . . . . . . . . o . . . . . . . . . . . . . . o . . . . . . . . . . . . .o
  8.  I felt like something good was going to happen. . . . . . . . . . . . . . . .o  . . . . . . . . . . . . . o . . . . . . . . . . . . . . o . . . . . . . . . . . . .o
  9.  I felt like things I did before didn’t work out right. . . . . . . . . . . . . . .o  . . . . . . . . . . . . . o . . . . . . . . . . . . . . o . . . . . . . . . . . . .o
10. I felt scared.  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .o  . . . . . . . . . . . . . o . . . . . . . . . . . . . . o . . . . . . . . . . . . .o
 DURING THE PAST WEEK  Not At All  A Little  Some  A Lot
11. I didn’t sleep as well as I usually sleep. .  . . . . . . . . . . . . . . . . . . . . . . . .o  . . . . . . . . . . . . . o . . . . . . . . . . . . . . o . . . . . . . . . . . . .o
12. I was happy. .  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .o  . . . . . . . . . . . . . o . . . . . . . . . . . . . . o . . . . . . . . . . . . .o
13. I was more quiet than usual..  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .o  . . . . . . . . . . . . . o . . . . . . . . . . . . . . o . . . . . . . . . . . . .o
14. I felt lonely, like I didn’t have any friends. .  . . . . . . . . . . . . . . . . . . . . .o  . . . . . . . . . . . . . o . . . . . . . . . . . . . . o . . . . . . . . . . . . .o
15. I felt like kids I know were not friendly or that 
 they didn’t want to be with me..  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .o  . . . . . . . . . . . . . o . . . . . . . . . . . . . . o . . . . . . . . . . . . .o
 DURING THE PAST WEEK  Not At All  A Little  Some  A Lot
16. I had a good time.  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .o  . . . . . . . . . . . . . o . . . . . . . . . . . . . . o . . . . . . . . . . . . .o
17. I felt like crying..  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .o  . . . . . . . . . . . . . o . . . . . . . . . . . . . . o . . . . . . . . . . . . .o
18. I felt sad..  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .o  . . . . . . . . . . . . . o . . . . . . . . . . . . . . o . . . . . . . . . . . . .o
19. I felt people didn’t like me..  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .o  . . . . . . . . . . . . . o . . . . . . . . . . . . . . o . . . . . . . . . . . . .o
20. It was hard to get started doing things..  . . . . . . . . . . . . . . . . . . . . . . .o  . . . . . . . . . . . . . o . . . . . . . . . . . . . . o . . . . . . . . . . . . .o
www.brightfutures.org
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Evidence-Based Recommendations for Lipid Assessment
Excerpted from A Supplement to Pediatrics: Expert Panel on Integrated Guidelines for Cardiovascular Health     
and Risk Reduction in Children and Adolescents: Summary Report, Dec. 2011, Vol. 128, Supplement 5
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have been heavily discussed, it 
appears that universal screen-
ing will capture numerous 
cases of dyslipidemias that 
may have been missed with 
targeted screening approach-
es alone. 
Current guidelines call for uni-
versal screening between ages 
9 to11and again between ages 
18 to 21, prior to the transi-
tion to adult care. Outside of 
these times, targeted screen-
ing recommendations remain 
in place. Ideally, a fasting lipid 
profile would be obtained. 
However, there are numerous 
instances when a patient is 
present in clinic and likely will 
not return in a fasting state. 
Non-fasting lipid profiles can 
be used in this case. With the 
non-fasting lipid profile, the 
marker of interest is the non-
HDL cholesterol level. Adult 
studies have demonstrated 
that this is an effective screen-
ing tool for lipid abnormalities. 
When a non-fasting profile is 
obtained, triglycerides and 
LDL cholesterol levels are not 
reliable, as they have not been 
cleared by fasting. 
Cut-offs for abnormalities are 
based on normal values de-
rived from the Lipid Research 
Clinical Prevalence Study. 
Acceptable values are levels 
below the 75th percentile, 
borderline are those between 
the 75th and 95th percentiles, 
and elevated are those levels 
above the 95th percentile. 
Specific values are listed in the 
table below. 
The main question after 
obtaining levels is how to 
respond to abnormal levels. 
Diet and exercise remain the 
mainstay of therapy. Diet 
• 7 •
Table 1:
PERCENTILE TC LDL TG † ‡ HDL † NON-HDL
Acceptable < 75th <170 <110 <75 (<90) ≥45 <120
Borderline 75
th
–95th 170–199 110–129 75–99 (129) 40–44 120–144
Elevated > 95th ≥200 ≥130 ≥100 (≥130) <40 ≥145
TC = total cholesterol; TG = triglycerides
† Not established by NCEP, these values are taken from NHANES study values
‡ Values are for children <10 years and children ≥10 years
modification includes a reduc-
tion of consumption of total 
cholesterol to 200 mg/day and 
saturated fat comprised 7% of 
calories. This is in comparison 
to a healthy diet of 300 mg/
day of cholesterol and 10% of 
calories derived from saturated 
fat. Physical activity primarily 
affected HDL cholesterol and 
triglyceride levels. Both the 
American Academy of Pediatric 
and the American Heart Asso-
ciation recommend 60 minutes 
per day of moderate to vigor-
ous physical activity. However, 
if after a six-month trial of 
lifestyle modification the levels 
remain elevated, a referral to 
a cardiologist or other lipid 
specialist may be warranted for 
medication management. 
Pediatric Lipid Screening Guidelines   
(continued from page 4)
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The  EPSDT Care for Kids Newsletter  is published 
three times a year, in print and online, as a joint 
effort of the Iowa Prevention of Disabilities Policy 
Council, the Iowa Department of Human Services, 
the Iowa Department of Public Health, and the 
Center for Disabilities and Development, which is 
nationally designated as Iowa’s University Center for 
Excellence on Disabilities. The goal of this newsletter 
is to inform Iowa health care professionals about 
the EPSDT Care for Kids program, to encourage 
them to make use of this important resource, and 
to provide them with information about a wide 
range of developments in the field of health care. 
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